Indocyanine Green (ICG) in Robotic Gastrectomy: A Retrospective Review of Lymphadenectomy Outcomes for Gastric Cancer.
Chul-Hyo JeonSo Jung KimHan-Hong LeeKyo-Young SongHo-Seok SeoPublished in: Cancers (2023)
Radical gastrectomy is essential for gastric cancer treatment. While guidelines advise dissecting at least 16 lymph nodes, some research suggests over 30 nodes might be beneficial. This study assessed ICG-guided robotic gastrectomy's effectiveness in thorough lymph node dissection. We analyzed data from 393 stage II or III gastric cancer patients treated at Seoul St. Mary's Hospital from 2016-2022. Patients were categorized into conventional laparoscopy (G1, n = 288), ICG-guided laparoscopy (G2, n = 61), and ICG-guided robotic surgery (G3, n = 44). Among 391 patients, 308 (78.4%) achieved proper lymphadenectomy. The ICG-robotic group (G3) showed the highest success rate at 90.9%. ICG-guided robotic surgery was a significant predictor for achieving proper lymphadenectomy, with an odds ratio of 3.151. In conclusion, ICG-robotic gastrectomy improves lymphadenectomy outcomes in selected gastric cancer cases, indicating a promising surgical approach for the future.
Keyphrases
- robot assisted
- fluorescence imaging
- lymph node
- sentinel lymph node
- minimally invasive
- photodynamic therapy
- early stage
- lymph node metastasis
- healthcare
- end stage renal disease
- neoadjuvant chemotherapy
- systematic review
- randomized controlled trial
- newly diagnosed
- emergency department
- squamous cell carcinoma
- prognostic factors
- deep learning
- metabolic syndrome
- rectal cancer
- big data
- type diabetes
- prostate cancer
- glycemic control
- radiation therapy
- electronic health record